Noval Vaccine Formulations for Chagas Disease
This special issue belongs to
|Research & Reviews: A Journal of Pharmacology
Deadline for Manuscript Submission
|March 31st, 2023
Deadline for Publication
|April 15, 2023
Special Issue Description
Trypanosoma cruzi, a parasite that only exists in the Americas and spreads to humans and animals by insect vectors, is what causes Chagas disease (mainly, in rural areas of Latin America where poverty is widespread).
Another name for Chagas disease (T. cruzi infection) is American trypanosomiasis. This research aims to find novel vaccines to cure this disease to cure people.
* Novel Vaccines
* Chagas Disease
* Trypanosoma cruzi
* Immune system
* Medical diagnosis
Manuscript Submission information
Manuscripts should be submitted online by registering and logging in to this link. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed.
Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent on email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.